Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -30.11%171.22B | -40.18%33.44B | -17.32%244.98B | -18.67%60.67B | -24.63%63.41B | -17.63%64.99B | -4.72%55.9B | 28.55%296.31B | -6.22%74.6B | 23.26%84.13B |
| Cost of revenue | -40.59%150.71B | -50.17%29.42B | -6.25%253.69B | -12.83%62.13B | -15.86%65.54B | -2.34%66.97B | 11.72%59.05B | 30.31%270.59B | -0.15%71.27B | 22.95%77.9B |
| Gross profit | 335.46%20.5B | 227.66%4.02B | -133.86%-8.71B | -143.80%-1.46B | -134.15%-2.13B | -119.12%-1.98B | -154.01%-3.15B | 12.57%25.72B | -59.25%3.33B | 27.24%6.24B |
| Operating expense | 0.95%13.37B | -24.41%2.1B | 21.52%13.24B | 88.99%5.34B | 21.56%3.3B | -32.38%1.82B | 4.51%2.78B | 5.28%10.9B | -21.99%2.82B | 17.14%2.71B |
| Selling and administrative expenses | 6.72%10.89B | --2.15B | --10.21B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | 6.72%10.89B | --2.15B | --10.21B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | -1.92%3.16B | --4M | --3.22B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other operating income | 259.38%690M | --47M | --192M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 132.52%7.14B | 132.26%1.91B | -248.06%-21.95B | -1,440.43%-6.8B | -254.09%-5.43B | -149.75%-3.8B | -287.50%-5.93B | 18.60%14.82B | -88.87%507M | 36.30%3.52B |
| Net non-operating interest income (expenses) | -134.36%-567M | 2,848.84%1.27B | 585.29%1.65B | 3,808.70%1.71B | -1,533.33%-1.23B | 1,105.36%1.13B | 140.19%43M | 29.17%-340M | 61.98%-46M | 39.52%-75M |
| Non-operating interest income | -75.17%553M | 1,423.23%1.51B | 1,740.50%2.23B | 3,003.13%1.99B | -2,727.91%-1.13B | 14,033.33%1.27B | 1,880.00%99M | 450.00%121M | 433.33%64M | 616.67%43M |
| Non-operating interest expense | 94.11%1.12B | 328.57%240M | 25.16%577M | 154.55%280M | -19.49%95M | 20.66%146M | -50.00%56M | -8.17%461M | -17.29%110M | -9.23%118M |
| Net investment income | 71.35%1.85B | 885.23%867M | -22.75%883M | 66.21%1.08B | -83.70%88M | -3,304.55%-705M | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -77.85%-530M | -123.15%-812M | 153.76%1.15B | -173.76%-298M | 270.13%3.51B | -32.66%736M | ||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -168.29%-239M | 86.00%-35M | 104.68%350M | 508.33%365M | -11.20%111M | 209.73%124M | -352.53%-250M | -53.53%171M | -36.84%60M | 5.93%125M |
| Special income (charges) | -2.26B | 0 | ||||||||
| Less:Write off | ---- | ---- | --2.26B | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | 110.24%21M | -3,650.00%-75M | -16.00%-29M | -164.67%-205M | 60.00%-2M | -101.70%-6M | ||||
| Income before tax | 131.73%6.33B | 176.01%3.14B | -230.95%-19.95B | -248.04%-6.09B | -243.77%-5.17B | -184.59%-4.55B | -292.95%-4.14B | 10.02%15.23B | 36.98%4.12B | -12.86%3.6B |
| Income tax | 54.65%2.58B | 294.16%831M | -69.80%1.67B | -120.01%-349M | -89.88%120M | 19.86%2.32B | -165.75%-428M | 57.26%5.52B | 57.40%1.74B | 32.81%1.19B |
| Net income | 117.35%3.75B | 162.39%2.31B | -322.52%-21.62B | -342.07%-5.74B | -319.58%-5.29B | -299.88%-6.87B | -348.39%-3.71B | -6.02%9.71B | 25.11%2.37B | -25.47%2.41B |
| Net income continuous operations | 117.36%3.75B | 162.37%2.31B | -322.52%-21.62B | -342.22%-5.74B | -319.44%-5.29B | -299.85%-6.87B | -348.46%-3.71B | -6.03%9.71B | 25.05%2.37B | -25.46%2.41B |
| Noncontrolling interests | 707.06%1.63B | 520.88%565M | -146.22%-269M | 67.21%-281M | -104.17%-43M | -106.09%-36M | 149.73%91M | -14.79%582M | -663.82%-857M | 394.57%1.03B |
| Net income attributable to the company | 109.92%2.12B | 146.01%1.75B | -333.79%-21.35B | -269.14%-5.46B | -480.23%-5.25B | -340.22%-6.84B | -326.69%-3.8B | -5.41%9.13B | 85.09%3.23B | -61.49%1.38B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 109.92%2.12B | 146.01%1.75B | -333.79%-21.35B | -269.14%-5.46B | -480.23%-5.25B | -340.22%-6.84B | -326.69%-3.8B | -5.41%9.13B | 85.09%3.23B | -61.49%1.38B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 107.96%28.65 | 139.34%25.22 | -333.29%-359.94 | -268.71%-91.98 | -479.47%-88.53 | -339.70%-115.32 | -326.30%-64.11 | -5.60%154.29 | 84.94%54.52 | -61.57%23.33 |
| Diluted earnings per share | 107.96%28.65 | 139.34%25.22 | -333.68%-359.94 | -268.99%-91.98 | -480.28%-88.53 | -340.10%-115.32 | -326.62%-64.11 | -5.53%154.03 | 85.01%54.43 | -61.57%23.28 |
| Dividend per share | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%22 | 0.00%22 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |